The growing importance of antibiotic resistance on clinical outcomes and cost of care underscores the need for optimization of current diagnostics. For a number of bacterial species antimicrobial resistance can be unambiguously predicted based on their genome sequence. In this study, we sequenced the genomes and transcriptomes of 414 drug-resistant clinical Pseudomonas aeruginosa isolates. By training machine learning classifiers on information about the presence or absence of genes, their sequence variation, and gene expression profiles, we generated predictive models and identified biomarkers of susceptibility or resistance to four commonly administered antimicrobial drugs. Using these data types alone or in combination resulted in high (0.8-0.9) or very high (>0.9) sensitivity and predictive values, where the relative contribution of the different categories of biomarkers strongly depended on the antibiotic. For all drugs except for ciprofloxacin, gene expression information substantially improved diagnostic performance. Our results pave the way for the development of a molecular resistance profiling tool that reliably predicts antimicrobial susceptibility based on genomic and transcriptomic markers.
Introduction
The rise of antibiotic resistance is a public health issue of greatest importance (Cassini et al. 2019) . Growing resistance hampers the use of conventional antibiotics and leads to increased rates of ineffective empiric antimicrobial therapy. If not adequately treated, infections cause suffering, incapacity and death, and impose an enormous financial burden on healthcare systems and on society in general (Alanis 2005; Fair and Tor 2014; Gootz 2010) . Despite growing medical need, FDA approvals of new antibacterial agents have substantially decreased over the last 20 years (Kinch et al. 2014) . Alarmingly, there are only few agents in clinical development for the treatment of infections caused by multidrug-resistant Gram-negative pathogens (Bush and Page 2017) .
Pseudomonas aeruginosa , the causative agent of severe acute as well as of chronic persistent infections, is particularly problematic. The opportunistic pathogen exhibits high intrinsic antibiotic resistance and frequently acquires resistance conferring genes via horizontal gene transfer (Lister, Wolter, and Hanson 2009; Partridge et al. 2018 ) . Furthermore, the accelerating development of drug-resistance due to the acquisition of drug resistance-associated mutations poses a serious threat.
The lack of new antibiotic options underscores the need for optimization of current diagnostics. Diagnostic tests are a core component in modern healthcare practice.
Especially in the light of rising multidrug-resistance, high-quality diagnostics becomes increasingly important. However, to provide information as the basis for infectious disease management is a difficult task. Antimicrobial susceptibility testing (AST) has experienced little change over the years. It still relies on culture-dependent methods and as a consequence, clinical microbiology diagnostics is labor-intensive and slow.
Culture-based AST requires 48h (or longer) for definitive results, which leaves physicians with uncertainty about the best drugs to prescribe to individual patients.
This delay also contributes to the spread of drug-resistance (López-Causapé et al. 2018; Oliver et al. 2015) .
The introduction of molecular diagnostics could become an alternative to culture-based methods and could be critical in paving the way to fight antimicrobial resistance. Identification of genetic elements of antimicrobial resistance promises a deeper understanding of the epidemiology and mechanisms of resistance and could lead to a timelier reporting of the resistance profiles as compared to conventional culture-based testing. It has been demonstrated that for a number of bacterial species antimicrobial resistance can be highly accurately predicted based on information derived from the genome sequence (Gordon et al. 2014; Bradley et al. 2015; Moradigaravand et al. 2018) . However, in the opportunistic pathogen P. aeruginosa even full genomic sequence information is insufficient to predict antimicrobial resistance in all clinical isolates (Kos et al. 2015) . P. aeruginosa exhibits a profound phenotypic plasticity mediated by environment-driven flexible changes in the transcriptional profile (Dötsch et al. 2015) . For example, P. aeruginosa adapts to the presence of antibiotics with the over-expression of the mex genes, encoding the antibiotic extrusion machineries MexAB -OprM, MexCD -OprJ, MexEF -OprN and MexXY -OprM. Similarly, high expression of the ampC encoded intrinsic beta-lactamase confers antimicrobial resistance Goli et al. 2018; Haenni et al. 2017; Juan et al. 2017) . Those transcriptional responses are frequently fixed in clinical P. aeruginosa strains, e.g. due to mutations in negative regulators of gene expression (Frimodt-Møller et al. 2018; Juarez et al. 2018) . Thus, the isolates develop an environment-independent resistance phenotype. Up-regulation of intrinsic beta-lactamases as well as over-expression of efflux pumps that contribute to the resistance phenotype make gene-based testing a challenge, because it is difficult to predict from the genomic sequence, which (combinations of) mutations would lead to an upregulation of resistance conferring genes (Llanes et al. 2004; Schniederjans, Koska, and Häussler 2017; Fernández and Hancock 2012) .
In this study, we investigated whether we can reliably predict antimicrobial resistance in P. aeruginosa using not only genomic but also quantitative gene expression information. For this purpose, we sequenced the genomes of 414 drug-resistant clinical P. aeruginosa isolates and recorded their transcriptional profiles .
We built predictive models of antimicrobial susceptibility/resistance to four commonly administered antibiotics by training machine learning classifiers. From these classifiers we inferred candidate marker panels for a diagnostic assay by selecting resistance-and susceptibility-informative markers via feature selection. We found that the combined use of information on the presence/absence of genes, their sequence variation and gene expression profiles can predict resistance and susceptibility in clinical P. aeruginosa isolates with high or very high sensitivity and predictive value.
Results
Taxonomy and antimicrobial resistance distribution of 414 DNA and mRNA sequenced clinical P. aeruginosa isolates 414 P. aeruginosa isolates were collected from clinical microbiology laboratories of hospitals across Germany and at sites in Spain, Hungary and Romania ( Figure 1A ).
For all isolates, the genomic DNA was sequenced and transcriptional profiles were recorded. This enabled us to not only use the full genomic information but also information on the gene expression profiles as an input to machine learning approaches.
We inferred a maximum likelihood phylogenetic tree based on variant nucleotide sites ( Figure 1B ). The tree was constructed by mapping the sequencing reads of each isolate to the genome of the P. aeruginosa PA14 reference strain and then aligning the consensus sequences for each gene. The isolates exhibited a broad taxonomic distribution and separated into two major phylogenetic groups. One included PAO1, PACS2, LESB58, and a cluster of high-risk clone ST175 isolates; the other included PA14, as well as one large cluster of high-risk clone ST235 isolates. Both groups comprised several further clades with closely related isolates of the same sequence type as determined by multi-locus sequencing typing (MLST).
Next, we recorded antibiotic resistance profiles for all isolates regarding the four common anti-pseudomonas antimicrobials, tobramycin (TOB), ceftazidime (CAZ), ciprofloxacin (CIP), and meropenem (MEM) using agar dilution method. Most isolates of our clinical isolate collection exhibit antibiotic resistance against these four 6 antibiotics ( Figure 1C , Supplementary Table S1) . One third had a multidrug resistant (MDR) phenotype, defined as non-susceptible to at least three different classes of antibiotics (Magiorakos et al. 2012 ) . genomes, which we included as an additional feature. We evaluated SNP and GPA groups in combination with gene expression information for 6,026 genes ( Figure 2 ).
For each drug we randomly assigned isolates to a training set that comprised 80% of the resistant and susceptible isolates, respectively, and the remaining 20% to a validation set. Parameters of machine learning models were optimized on the training set and their value assessed in cross-validation (CV), while the validation set was used to obtain another independent performance estimate. We trained several machine learning classification methods on SNPs, GPA and expression features individually and in combination for predicting antibiotic susceptibility or resistance of isolates and evaluated the classifier performances. As the underlying gold standard 8 for evaluation, we determined MIC (minimal inhibitory concentration) values of all clinical isolates with agar dilution according to CLSI guidelines (CLSI 2018) .
Figure 2:
Training and validating a diagnostic classifier for antimicrobial susceptibility prediction for four different drugs based on genomic (GPA/SNPs) and transcriptomic profiles (EXPR). The best data type combination was determined using 80% of the data in standard and phylogenetically-informed cross-validation (cv) and further validated on the remaining 20% of the data.
We calculated the sensitivity and predictive value of resistance (R) and susceptibility (S) assignment, as well as the macro F1-score, as an overall performance measure based of a classifier trained on a specific data type combination. The sensitivity reflects how good that classifier is in recovering the assignments of the underlying gold standard, representing the fraction of susceptible, or resistant, samples, respectively. The predictive value reflects how trustworthy the assignments of this particular classifier are, representing the fraction of correct assignments of all susceptible, or resistant assignments, respectively. The F1-score is the harmonic mean of the sensitivity and predictive value for a particular class, i.e. susceptible or resistant. The macro F1-score is the average over the two F1-scores.
We used the support vector machine (SVM) classifier with a linear kernel, as in (Weimann et al. 2016) , to predict sensitivity or resistance to four different antibiotics.
Parameters were optimized in nested CV and performance estimates averaged over five repeats of this setup. The combined use of i) GPA, ii) SNPs and iii) information on gene expression resulted in high (0.8-0.9) or very high (>0.9) sensitivity and predictive values (Figure 3) . Notably, the relative contribution of the different information sources to the susceptibility and resistance sensitivity strongly depended on the antibiotic. To assess the effect of the classification technique, we compared the performance of an SVM classifier with a linear kernel to that of random forests, and logistic regression, which we and others have used successfully for related phenotype prediction problems (Her and Wu 2018; Asgari et al. 2018; Wheeler, Gardner, and Barquist 2018) . For this purpose we used the data type combination with the best macro F1-score in resistance prediction with the SVM. As before, we evaluated the classification performance in random cross-validation, and on a held-out test data set. In addition, we performed a phylogeny-aware partitioning of our data set, to assess phylogenetic generalization ability of our technique. and expression information gave the most reliable classification results, whereas for ciprofloxacin we found that only using SNPs provided the best performance (Table 1 and Supplementary Table S3 ). Thus for the remainder of the manuscript, we will focus on the results obtained with classifiers trained on those data type combinations. 
A candidate drug resistance marker panel
We determined the minimal number of molecular features required to obtain the highest macro F1-score for each drug. We inferred the number of features contributing to the classification from the number of non-zero components of the SVM weight vectors, using a standard cross-validation set-up. For each value of the C parameter, which controls the amount of regularization imposed on the model, the cross-validation procedure was repeated five times ( Figure 4 , Supplementary Table   S4 ). Performance of antimicrobial resistance prediction peaked for the candidate classifiers using between 50 and 100 features. Notably, the ciprofloxacin classifier required only two SNPs until the learning curve performance was almost saturated, whereas classifiers of drugs that included expression and gene presence/absence markers required more feature (>50) to reach saturation.
Figure 4:
The number of features used by the support vector machine classifier (top panels) and corresponding classification performance (bottom panels) varies with the hyperparameter C. The SVM resistance/susceptibility classifier was evaluated in five repeats of ten-fold nested cross-validation. Each panel depicts the results for a different drug (CAZ, CIP, MER, TOB) based on the best data type combination (GPA+EXPR/SNPs). The model with the fewest features within one standard deviation of the maximal performance was selected as the most suitable diagnostic classification model (red) (Supplementary Table S5 ).
Next, we determined the C parameter resulting in the least complex SVM model within one standard deviation of the peak performance, i.e. with the best F1-score macro and as few as possible features for each drug (Friedman, Hastie, and Tibshirani 2001) . We chose our candidate marker panel for each drug as the set of all non-zero features, and designated the respective model as the most suitable diagnostic classifier. We used SNP information for ciprofloxacin resistance and susceptibility prediction and the combination of GPA and expression features for tobramycin, meropenem and ceftazidime. We refer to each of these classifiers as the candidate classifier for susceptibility and resistance prediction for a particular drug.
The ciprofloxacin candidate marker panel contained 50 SNPs. The meropenem, ceftazidime and tobramycin marker lists consisted of 93, 37 and 59 expression and GPA features. The complete list of candidate markers for the prediction of resistance against the four antibiotics is given in Supplementary Table S5 . This list includes the candidate markers of the three input features namely GPA, gene expression and SNPs alone and in combination. Table 2 is a shortlist of the panel markers for each drug based on the data combination that had allowed us to train the most reliable classifier. To test the performance of the candidate marker panel-based classifiers on an independent set of clinical P. aeruginosa isolates, we used them to predict antibiotic resistance for the samples of the validation dataset ( Figure 5 , Supplementary Table   S6 ). On this held out data we obtained an F1-sore for all drugs that was similarly high as before: namely this was for meropenem 0.95, ceftazidime 0.77 and tobramycin 0.96, using gene expression and gene presence/absence features and 0.87 for ciprofloxacin using SNP information. These results indicate that the diagnostic 18 classifiers have good generalization abilities when applied to new samples. We observed more variability across drugs than in nested cross-validation, which is expected due to the smaller size of the validation set. Figure 5 : Performance of the support vector machine (SVM) classifier for antimicrobial resistance and susceptibility prediction for different data types, different drugs and different evaluation schemes. The SVM performance was summarized by the F1-score and is shown for standard cross-validation (standard_cv, blue) and cross-validation using phylogenetically related blocks of isolates (block_cv, red) based on the training data set (80% of the isolates) and for the validation data set (green; 20% of the isolates). EXPR: gene expression; GPA: gene presence and absence with indel information. SNPs: short nucleotide polymorphisms.
Improvement of assignment accuracy with increasing sample numbers
We next investigated how prediction performance depended on the number of samples used for classifier training. We trained the SVM classifiers on random subsamples of different sizes of the full data set with 414 isolates. For each model we recorded the macro F1-score in five repeats of ten-fold nested cross-validation ( Figure 6 ). The classification performance saturates for all our classifiers well before using all available training samples, suggesting that when adding more isolates for resistance classification, the classification performance would improve only very slowly. Markers potentially remaining undiscovered in our study might have very small effect sizes, requiring much larger data set sizes for their detection.
Interestingly, the number of samples required until the performance curve plateaued depends on the drugs and data types used. For ciprofloxacin, the performance of susceptibility/resistance prediction based on SNPs saturated quickly, likely due to the large impact of the known mutations in the quinolone resistance determining region (QRDR), whereas the classifiers for the other three drugs, which were trained on expression and gene presence/absence information required more samples until the F1-score plateaued. For these classifiers the dispersion of the macro F1-score for subsets of the data with fewer samples is also considerably higher than for the ciprofloxacin SNP models. isolates of a given block were only allowed to be either in the training or test folds (Figure 2, 5) . Overall, for all four candidate diagnostic classifiers, we found that the performance estimates were only slightly lower than those obtained with standard cross-validation. This confirmed that the various P. aeruginosa phylogenetic subgroups possess similar mechanisms and molecular markers for the resistance phenotype and that the identified markers are distinctive for resistance/susceptibility instead of phylogenetic relationships.
Notably, this was different for some suboptimal data type combinations, such as for predicting tobramycin resistance using SNPs or gene expression, where a substantially lower discriminative performance was achieved in block-compared to random cross-validation (macro F1-score difference > 0.2, Supplementary Table S3 ).
These results suggest that -despite the observed independence of the presence of genetic resistance markers and bacterial phylogeny -for some antibiotics we found a non-negligible phylo-group-dependent performance effect. This underlines the importance of assessing the impact of the phylogeny on the antimicrobial resistance prediction.
Misclassified isolates are more frequent near the MIC breakpoints
We tested whether we could detect an overrepresentation of misclassified samples among the samples with a MIC value close to the breakpoints compared to samples with higher or lower MIC values, selecting samples from equidistant intervals (in log space) around the breakpoint. We report only the strongest overrepresentation for each drug after multiple testing correction. For ciprofloxacin significantly more samples with a MIC between 0.5 and 8 were misclassified (31 of 139 samples (22%)) than samples with a MIC smaller than 0.5 or larger than 8 (7 of 219 samples (3%)) (Fisher exact test with an FDA adjusted p-value of 6.2 •10 -8 ; Figure 7 ). For ceftazidime, we found that 46 of 177 samples (26%) with a MIC between 4 and 64 were misclassified whereas only 21 of 157 (13%) of samples with a MIC smaller or higher than those values were misclassified (adjusted p-value: 0.014). For meropenem, we found that 26 of 207 samples (13%) with a MIC between 1 and 16 were misclassified, but only 8 of 147 (5%) of all samples with a MIC smaller or higher than those values were misclassified (adjusted p-value: 0.05). For tobramycin, no significant difference was found. Misclassified and correctly classified samples for the training data set (80%) were inferred in a ten-fold cross-validation. An SVM trained on the training data set was used to predict resistance/susceptibility of the validation samples (20%). The number of misclassified samples in the training (80%) and validation set were aggregated.
Discussion
One of the most powerful weapons in the battlefield of drug-resistant infections is rapid diagnostics of resistance. Earlier and more detailed information on the pathogens antimicrobial resistance profile has the potential to change antimicrobial prescribing behavior and improve the patient's outcome. The demand for faster results has initiated investigation of molecular alternatives to today's culture-based clinical microbiology procedures. However, for the successful implementation of robust and reliable molecular tools, it is critical to identify the entirety of the molecular determinants of resistance . Failure to detect resistance can lead to the administration of ineffective or sub-optimal antimicrobial treatment. This has direct consequences for the patient; and poses significant risks especially in the critically ill patient.
Conversely, failing to identify susceptibility may result in the avoidance of a drug despite the fact that it would be suitable to treat the pathogen, in the extreme case leading to patient death due to a lack of known treatment options. Overtreatment could also be a consequence and the needless use of broad-spectrum antibiotics.
This drives costs in the hospital, puts patients at risk for more severe side effects and may contribute to the development of drug resistance by applying undesired selective pressures.
In this study, we show that without any prior knowledge on the molecular mechanisms of resistance, machine learning approaches using genomic and transcriptomic features can provide high antibiotic resistance assignment capabilities for the opportunistic pathogen P. aeruginosa . The performance of drug resistance prediction was strongly dependent on the antibiotic.
Ciprofloxacin resistance and susceptibility prediction mostly relied on SNP information. Particularly two SNPs in the quinolone resistance determining region (QRDR) of gyrA and parC had the strongest impact on the classification (Supplementary Table S3 ). This is an expected finding as quinolone antibiotics act by binding to their targets, gyrase and topoisomerase IV (Bruchmann et al. 2013) ; and target-mediated resistance caused by specific mutations in the encoding genes is the most common and clinically significant form of resistance (del Barrio-Tofiño et al. 2017) . Although the sensitivity to predict resistance and susceptibility from only gene expression data was also high towards ciprofloxacin, there was no added value of using information on gene expression in addition to SNP information. Nevertheless, for the design of a diagnostic test system, it might be of value to include also gene expression information as a fail-safe strategy. Interestingly, among the gene expression classifiers that were associated with ciprofloxacin susceptibility/resistance, we found prtN, which is involved in pyocyanin production.
Pyocyanin has previously been demonstrated to alter ciprofloxacin susceptibility in P. aeruginosa (Grant et al. 2010) . Furthermore, we found that altered expression and sequence of genes of the conjugation machinery such as traG , trbE, trbI and the closely located transcriptional regulator merD influenced classification. This is interesting because, it has been shown before that quinolone resistance inducing QRDR mutations do not only appear as a result of de novo target modification but are also frequently obtained by conjugation (Pitondo-Silva et al. 2015) .
For the prediction of tobramycin susceptibility and resistance, the machine learning classifiers performed almost equally well when the three input data types (SNPs, GPA and gene expression) were used individually (sensitivity and predictive values >0.8). Remarkably, the combined use of the GPA and the gene expression data sets improved the classification performance. Although SNP information also was predictive of tobramycin resistance, it did not further improve the classification performance when combined with the other feature types. GPA information alone was the most important data type for classifying tobramycin resistance or susceptibility. The majority of aminoglycoside resistant clinical isolates harbor genes encoding for aminoglycoside modifying enzymes (AMEs). The AMEs are very diverse but are usually encoded by genes located on mobile genetic elements, including integrons and transposons. In accordance, the presence of respective markers that indicate the presence of these mobile elements was found to be strongly associated with tobramycin resistance (e.g. qacE, delta1 , sul1 or folP ). However, the most influential discriminator was the presence of the emrE gene. EmrE has been described to directly impact on aminoglycoside resistance by mediating the extrusion of small polyaromatic cations (X.-Z. Li, Poole, and Nikaido 2003) . Expression of ptsP was also associated with tobramycin resistance. This gene has previously already been associated with tobramycin resistance (Schurek et al. 2008) . The performance of GPA-based prediction increased further when gene expression values were included. We found e.g. amrB ( mexY ), which encodes a multidrug efflux pump known to confer to aminoglycoside resistance (Westbrock-Wadman et al. 1999; Lau, Hughes, and Poole 2014) , as one of the top candidates within the marker panel. This confirms that expression of efflux pumps is an important bacterial trait that drives the resistance phenotype in P. aeruginosa . Tobramycin resistance/susceptibility was associated especially with an altered expression or SNPs within genes involved in type 4 pili motility ( pilB pilT2, pilY1, pilQ, pilH ) and the type three secretion system ( pcr genes). It has been proposed that surface motility can lead to extensive multidrug adaptive resistance as a result of the collective dysregulation of diverse genes (Sun et al. 2018) . Furthermore, the expression of the type III secretion effector gene, exoU , has been previously shown to be associated with antibiotic resistance to tobramycin in P. aeruginosa strains isolated from chronic otitis media infections (Park et al. 2017 ) .
For the correct prediction of meropenem resistance/susceptibility, gene presence/absence was most influential. Interestingly, in contrast to tobramycin resistance classification, we observed a substantial accumulation of indels in specific marker genes. Among these marker genes were ftsY, involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane, czcD, encoding a cobalt-zinc-cadmium efflux protein and oprD . Inactivation of the porin OprD is the leading cause of carbapenem non-susceptibility in clinical isolates (Köhler et al. 1999) . As expected, also a decreased oprD gene expression in the resistant group of isolates was identified as an important discriminator. Interestingly though, the most important gene expression marker was not the down-regulated oprD , but an up-regulation of the gene gbuA, encoding a guanidinobutyrase in the arginine dehydrogenase pathway, in the meropenem resistant group of isolates. The finding of gbuA expression in meropenem resistant P. aeruginosa isolates could be an interesting topic to further follow up. Furthermore, components encoding the MexAB-OprM efflux pump ( mexB, oprM ) were identified as important features associated with resistance. This efflux pump is known to export beta-lactams, including meropenem (Srikumar et al. 1998; X. Z. Li, Nikaido, and Poole 1995; Clermont, Brahimi, and Plesiat 2001) .
As observed for tobramycin, the correct prediction of ceftazidime resistance/susceptibility was strongly influenced by both, gene expression values (here ampC, fpvA, pvdD, algF ) and gene presence/absence (including presence of mobile genetic elements). AmpC is a known intrinsic beta-lactamase, able to hydrolyze cephalosporins (Lister, Wolter, and Hanson 2009) . Adding information on the gene expression considerably improved the performance of susceptibility and resistance sensitivity, which was not observed in a similar scale for any other antibiotic.
In conclusion, we demonstrate that extending the genetic features (SNPs and gene presence/absence) with gene expression values is key to improving performance.
Thereby relative contribution of the different categories of biomarkers to the susceptibility and resistance sensitivity strongly depended on the antibiotic. This is in stark contrast to the prediction of antibiotic resistance in many Enterobacteriaceae, where knowledge of the presence of resistance-conferring genes, such as beta-lactamases, is usually sufficient to correctly predict the susceptibility profiles.
However, analysis of the gene expression marker lists revealed that the resistance phenotype in the opportunistic pathogen P. aeruginosa (and possibly also in other non-fermenters) is multifactorial and that alterations in gene expression can alter the resistance phenotype quite substantially.
Intriguingly, we found that the performance of our classifiers improved if the isolates exhibited MIC values that were not close to the breakpoint. This was especially apparent for ciprofloxacin. It has been demonstrated that patients treated with levofloxacin for bloodstream infections caused by Gram-negative organisms for which MICs were elevated, yet still in the susceptible category, had worse outcomes than similar patients infected with organisms for which MICs were lower (Defife et al. 2009 ) . A possible explanation for treatment failure could be the presence of first-step mutations in gyrA that lead to MIC values near the breakpoint. If subjected to quinolones, those isolates can rapidly acquire second step mutations in parC that would then exhibit a fully resistant phenotype. An additional explanation might also be that generally MICs have a low level of reproducibility (Turnidge and Paterson 2007; Juan et al. 2012; Javed et al. 2018) . A non-accurate categorization due to uncertainty in testing near the MIC breakpoint can explain failure in the assignment of drug resistance by the machine learning classifiers.
Capturing the full repertoire of markers that are relevant for predicting antimicrobial resistance in P. aeruginosa will require further studies, to expand the predictive power of the established marker lists. The remaining misclassified samples in our study on the basis of these marker lists represent a valuable resource to uncover further spurious resistance mutations.
The broad use of molecular diagnostic tests promises more detailed and timelier information on antimicrobial resistant phenotypes. This would enable the implementation of early and more targeted, and thus more effective antimicrobial therapy for improved patient care. Importantly, a molecular assay system can easily be expanded to test for additional information such as the clonal identity of the bacterial pathogen or the presence of critical virulence traits. Thus, availability of molecular diagnostic test systems can also provide prognostic markers for disease outcome and give valuable information on the clonal spread of pathogens in the hospital setting. However, to realize the full potential of the envisaged molecular diagnostics, clinical studies will be needed to demonstrate that broad application of such test systems will have an impact in clinical decision-making, provide the basis for more efficient antibiotic use, and also decrease the costs of care.
Materials and Methods
Strain collection and antibiotic resistance profiling 
Colony screening
To rule out possible contaminations, all isolates were continuously re-streaked at least twice from single colonies. Only isolates with reproducible outcomes in phenotypic tests were included in the final panel, which furthermore passed DNA sequencing quality control (>85 % sequencing reads mapped to P. aeruginosa UCBPP-PA14 reference genome, total read GC content of 64-66 %).
RNA sequencing
For comparable whole transcriptome sequencing, all clinical isolates and the UCBPP-PA14 reference strain were cultivated at 37°C in LB broth and harvested in RNAprotect (Qiagen) at OD 600 = 2. Sequencing libraries were prepared using the ScriptSeq RNA-Seq Library Preparation Kit (Illumina) and short read data (single end, 50 bp) was generated on an Illumina HiSeq 2500 machine creating on average 3 million reads per sample.
The reads were mapped with Stampy (v1.0.23; (Lunter and Goodson 2011) ) to the UCBPP-PA14 reference genome (NC_008463.1), which is available for download from the Pseudomonas Genome database ( http://v2.pseudomonas.com ). Mapping and calculation of reads per gene (rpg) values was performed as described previously (Khaledi et al. 2016) . Expression counts were log-transformed (to deal with zero values we added one to the expression counts).
DNA sequencing
Sequencing libraries were prepared from genomic DNA using the NEBNext Ultra DNA Library Prep Kit (New England Biolabs) and sequenced in paired end mode on Illumina HiSeq or MiSeq machines, generating either 2x250 or 2x300 bp reads. On average 2.89 million reads were generated per isolate (ranging from 653,062 to 21,086,866 reads with at least 30 times total genome coverage per isolate). All reads were adapter and quality clipped using fastq-mcf (Andrews 2010 ) .
All sequencing data are available at NCBI's Gene Expression Omnibus (GEO) and Sequence Read Archive (SRA) under the accession numbers GSE123544
(RNA-sequencing reads) and PRJNA526797 (DNA-sequencing reads), respectively.
SNP calling
DNA-sequencing reads were mapped with Stampy as described above (see 
Phylogeny
Paired-end reads (read length 150, fragment size 200) of eight reference genomes were simulated using art_illumina (v2.5.8) with the default error profile at 20-fold coverage (Huang et al. 2012 
Pan-genome analysis and indel calling
The trimmed reads were assembled with SPAdes, v.3.0.1 using the --careful parameter (Bankevich et al. 2012) . The assembled genomes were annotated using Prokka (v1.12) (Seemann 2014 ) using the metagenome mode of Prokka for gene calling, as we had noticed that genes on resistance cassettes were often missed by the standard isolate genome gene calling procedure. The gene sequences were clustered into gene families using Roary (Page et al. 2015) . We observed that Roary frequently clustered together gene sequences of drastically varying lengths due to indels or start and stop codon mutations in those gene sequences and frequently also splits orthologous genes into more than one gene family. To overcome this behaviour we modified Roary to require at least 95% alignment coverage in the BLAST step ( https://github.com/hzi-bifo/Roary ).
For matching the Prokka annotation and the reference annotation of the PA14 strain we used bedtools (Quinlan 2014) 
Support vector machine classification
For applying cross-validation, the data set was split once randomly and once phylogenetically informed (see below) into k-folds (k set to 10, unless specified otherwise). Classifier hyperparameters were optimized on a k-1 fold sized partition, and performance of the optimally parameterized method was determined on the left out k fraction of the data. This was performed for all possible k partitions, assignments summarized and final performance measures obtained by averaging.
Comparison of different machine learning classifiers
We used the training set for hyperparameter tuning of the classifiers, i.e. a linear SVM, RF, and LR, optimizing the F1-score in ten-fold cross-validation and then evaluated the best trained classifier on the held-out set. The RF classifier was optimized for the macro F1-score over different hyperparameters: (i) the number of decision trees in the ensemble, (ii) the number of features for computing the best node split, (iii) the function to measure the quality of a split and (iv) the minimum number of samples required to split a node. The logistic regression and the linear SVM were optimized for the macro F1-score over: (i) the C parameter ( inverse to the regularization strength ) and (ii) class weights (to be balanced based on class frequencies or to be uniform over all classes). Subsequently we measured the performance of the optimized classifiers over accordingly generated, held-out sets of samples).
In clinical practice P. aeruginosa strains isolated from patients are likely to include sequence types that are already part of our isolate collection. To obtain a more conservative estimate of the performance of the antimicrobial susceptibility prediction, we also validated the classifiers on a held-out dataset composed of entirely new sequence types and also selected the folds in cross-validation to be non-overlapping in terms of their sequence types (block cross-validation). For partitioning the isolate collection into sequence types we used spectral clustering over the phylogenetic similarity matrix (von Luxburg 2007) . We obtained this matrix by applying a Gaussian kernel over the matrix of distances between isolates based on the branch lengths in the phylogenetic tree.
Multi Locus Sequence Typing (MLST)
Consensus fastq files for each isolate were created with SAMtools to extract the seven P. aeruginosa relevant MLST gene sequences ( acsA, aroE, guaA, mutL, nuoD, ppsA, trpE ) . Sequence type information was obtained from the Pseudomonas aeruginosa MLST Database ( https://pubmlst.org/paeruginosa/ ) (Jolley and Maiden 2010) .
Implementation
We encapsulated the sequencing data processing routines in a stand-alone package named seq2geno2pheno https://github.com/hzi-bifo/seq2geno2pheno . The SVM classification was conducted with Model-T https://github.com/hzi-bifo/Model-T , which is built on scikit-learn (Pedregosa et al. 2011 ) and was already used as the prediction engine in our previous work on bacterial trait prediction (Weimann et al. 2016) .
seq2geno2pheno also implements a framework to use a more broader set of classifiers, which we used to compare different classification algorithms for drug resistance prediction. Finally, we created a repository that includes scripts to re-produce the figures and analyses presented in this paper using the aforementioned packages https://github.com/hzi-bifo/Fighting_PA_AMR_paper .
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AxKo, MH, PG and GC generated data. Comparison of support vector machine, random forest, and logistic regression classifiers in antimicrobial resistance prediction, and their generalization ability. Training and performance estimates was performed in ten-fold cross-validation, where isolates were split either randomly (standard: std) or using phylogenetically related blocks of isolates (block). The classification was performed for each antibiotic using the best performing feature combinations for the SVM. The error bar shows the variability (standard deviation) in 10 test folds.
Supplementary Figure S2

Supplementary Figure 2:
Comparison of support vector machine, random forest, and logistic regression classifiers in antimicrobial resistance prediction, and their generalization ability. The classifiers were tuned in a ten-fold cross-validation; subsequently their performances are reported over the held-out set, where isolates were split either randomly (standard: std) or using phylogenetically related blocks of isolates (block).
Supplementary Figures S3-S6:
Phylogenetic tree of the 414 P. aeruginosa isolates used in this study. The branches leading towards two deeply branching clades were collapsed (CH4433 and ESP077, and CH4684, CH5206 and CH5387). The inner ring depicts the susceptibility of each isolate to ciprofloxacin, meropenem, tobramycin, and ceftazidime respectively; green susceptible, red resistant; rose intermediate resistant. The outer rings shows the susceptibility as assigned by the diagnostic genomic classifier (intermediate resistant samples were not assigned).
